The same clinical governance, infection control, equipment standards, and patient safety protocols required of any private hospital apply at our clinic
The estimated mean weight loss was 7.03 kg in the placebo group, 11.19 kg in the exercise group, 13.74 kg in the liraglutide group, and 16.88 kg in the combination group
This transaction follows Pfizers recent effort to rebuild its obesity portfolio after discontinuing three previous GLP-1 candidates due to issues such as elevated liver enzymes or insufficient Phase 1 data
The decision to continue or adjust your therapy is always personalized and revisited over time to ensure it remains safe and effective for you.
In cells, lipoic acid is swiftly reduced to dihydrolipoic acid, and in vitro studies indicate that dihydrolipoic acid is then rapidly exported from cells (3)
For weight management, these medications are typically prescribed for people with a BMI of 30 or higher, or 27 or higher with a weight-related health condition like diabetes, obstructive sleep apnea or high blood pressure